Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
TIVITY HEALTH, INC. (TVTY)
|
Add to portfolio |
|
|
|
| Price: |
$26.87
| | Metrics |
| OS: |
49.9
|
M
| |
66
|
% ROE
|
| Market cap: |
$1.34
|
B
| |
186175
|
% ROIC
|
|
Net debt:
|
$261
|
M
| |
1.7
|
x Debt/EBITDA
|
|
EV:
|
$1.6
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$150
|
M
| |
10.7
|
x EV/EBITDA
|
|
EBIT
|
$138
|
M
| |
11.6
|
x EV/EBIT
|
| EPS |
$1.75
| |
15.4
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 481.3 | 437.7 | 633.1 | 606.3 | 556.9 | 501.0 | 452.1 | 405.3 |
| Revenue growth | 9.9% | -30.9% | 4.4% | 8.9% | 11.2% | 10.8% | 11.6% | -38.9% |
| Cost of goods sold | 278.3 | 250.4 | 445.8 | 418.3 | 390.3 | 357.1 | 318.1 | 272.4 |
| Gross profit | 203.0 | 187.4 | 187.2 | 188.0 | 166.7 | 143.9 | 134.0 | 132.9 |
| Gross margin | 42.2% | 42.8% | 29.6% | 31.0% | 29.9% | 28.7% | 29.6% | 32.8% |
| Selling, general and administrative | 48.5 | 55.0 | 70.9 | 49.5 | 39.7 | 39.5 | 35.5 | 32.1 |
| Sales and marketing | 6.5 | 12.2 | 17.7 | 14.4 | 5.5 | | | |
| EBITA | 143.2 | 122.5 | 109.2 | 133.8 | 123.6 | 100.8 | 92.1 | 94.3 |
| EBITA margin | 29.8% | 28.0% | 17.2% | 22.1% | 22.2% | 20.1% | 20.4% | 23.3% |
| Amortization of intangibles | | | | | | 0.5 | 0.5 | 0.5 |
| EBIT | 143.2 | 122.5 | 109.2 | 133.8 | 123.6 | 100.3 | 91.6 | 93.8 |
| EBIT margin | 29.8% | 28.0% | 17.2% | 22.1% | 22.2% | 20.0% | 20.3% | 23.1% |
| Pre-tax income | 133.7 | 74.4 | 65.5 | 124.9 | 104.8 | 78.1 | 72.9 | 70.4 |
| Income taxes | 26.3 | 17.5 | 20.3 | 27.0 | 43.6 | 22.0 | 29.3 | 27.6 |
| Tax rate | 19.7% | 23.6% | 31.0% | 21.6% | 41.6% | 28.1% | 40.2% | 39.1% |
| Earnings from continuing ops | 107.4 | 56.9 | 45.2 | 97.9 | 61.2 | 55.6 | 44.0 | 42.8 |
| Earnings from discontinued ops | -2.5 | -280.5 | -332.0 | 0.9 | 2.5 | -184.7 | -75.0 | -48.4 |
| Net income | 104.9 | -223.6 | -286.8 | 98.8 | 63.7 | -129.1 | -30.9 | -5.6 |
| Net margin | 21.8% | -51.1% | -45.3% | 16.3% | 11.4% | -25.8% | -6.8% | -1.4% |
| |
| Diluted EPS | $2.13 | $1.16 | $0.96 | $2.27 | $1.44 | $1.46 | $1.19 | $1.18 |
| Shares outstanding (diluted) | 50.4 | 49.2 | 47.1 | 43.1 | 42.5 | 38.1 | 36.9 | 36.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|